Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity 2.0

This book, "Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity", presents five papers on human cytochrome P450 (CYP) and P450 reductase, three reviews on the role of CYPs in humans and their use as biomarkers, six papers on CYPs in microorganisms, and one study on CYP in ins...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (286 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05702nam-a2201405z--4500
001 993545869304498
005 20231214132838.0
006 m o d
007 cr|mn|---annan
008 202201s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000045751 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76512 
035 |a (EXLCZ)995400000000045751 
041 0 |a eng 
100 1 |a Dansette, Patrick M.  |4 edt 
245 1 0 |a Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity 2.0 
246 |a Cytochromes P450 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (286 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a This book, "Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity", presents five papers on human cytochrome P450 (CYP) and P450 reductase, three reviews on the role of CYPs in humans and their use as biomarkers, six papers on CYPs in microorganisms, and one study on CYP in insects. The first paper reports the in silico modeling of human CYP3A4 access channels. The second uses structural methods to explain the mechanism-based inactivation of CYP3A4 by mibefradil, 6,7-dihydroxy-bergamottin, and azamulin. The third article compares electron transfer in CYP2C9 and CYP2C19 using structural and biochemical methods, and the fourth uses kinetic methods to study electron transfer to CYP2C8 allelic mutants. The fifth article characterizes electron transfer between the reductase and CYP using in silico and in vitro methods, focusing on the conformations of the reductase. Then, two reviews describe clinical implications in cardiology and oncology and the role of fatty acid metabolism in cardiology and skin diseases. The second review is on the potential use of circulating extracellular vesicles as biomarkers. Five papers analyze the CYPomes of diverse microorganisms: the Bacillus genus, Mycobacteria, the fungi Tremellomycetes, Cyanobacteria, and Streptomyces. The sixth focuses on a specific Mycobacterium CYP, CYP128, and its importance in M. tuberculosis. The subject of the last paper is CYP in Sogatella furcifera, a plant pest, and its resistance to the insecticide sulfoxaflor. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
653 |a Antibiotics 
653 |a Bacillus 
653 |a biosynthetic gene clusters 
653 |a comparative analysis 
653 |a cytochrome P450 monooxygenase 
653 |a Mycobacterium 
653 |a P450 diversity percentage 
653 |a P450 profiling 
653 |a secondary metabolites 
653 |a NADPH-cytochrome P450 reductase (CPR) 
653 |a microsomal cytochrome P450 (CYP) 
653 |a Cytochrome b5 (CYB5) 
653 |a protein dynamics 
653 |a electron-transfer (ET) 
653 |a protein–protein interaction 
653 |a cytochromes P450 
653 |a CYP3A4 
653 |a active site access channels 
653 |a cavities boundaries 
653 |a minimal cost paths 
653 |a CYP139A1 
653 |a genome data mining 
653 |a host metabolism 
653 |a Mycobacterium tuberculosis 
653 |a polyketides 
653 |a tuberculosis 
653 |a cryptococcus 
653 |a cryptococcus neoformans 
653 |a CYP51 
653 |a fungal pathogens 
653 |a genome data-mining 
653 |a human pathogens 
653 |a CYP diversity analysis 
653 |a tremellomycetes 
653 |a trichosporon 
653 |a mechanism-based inhibitor 
653 |a crystal structure 
653 |a CYP4 genes 
653 |a genetic polymorphisms 
653 |a 20-HETE 
653 |a fatty acid 
653 |a arachidonic acid 
653 |a SNPs 
653 |a molecular functionality 
653 |a metabolism 
653 |a lamellar ichthyosis 
653 |a Bietti’s crystalline dystrophy 
653 |a cytochrome P450 
653 |a isoform 
653 |a membrane protein 
653 |a protein-membrane interactions 
653 |a enzyme substrate specificity 
653 |a mutagenesis 
653 |a molecular dynamics simulation 
653 |a Sogatella furcifera 
653 |a sulfoxaflor 
653 |a transcriptome 
653 |a RNA interference 
653 |a CYP2C8 
653 |a polymorphisms 
653 |a reactive oxygen species 
653 |a paclitaxel 
653 |a cytochrome P450 reductase 
653 |a electron transfer 
653 |a extracellular vesicles 
653 |a exosomes 
653 |a extrahepatic tissues 
653 |a plasma 
653 |a circulatory CYPs 
653 |a CYP450 
653 |a drug metabolism 
653 |a precision Cardio-Oncology 
653 |a precision medicine 
653 |a systems medicine 
653 |a cytochromes P450 monooxygenases 
653 |a Cyanobacteria 
653 |a gene-cluster diversity percentage 
653 |a mathematical formula 
653 |a phylogenetic analysis 
653 |a Streptomyces 
653 |a cytochrome P450 monooxygenases 
653 |a terpenes 
653 |a P450 blooming 
653 |a non-ribosomal peptides 
653 |a cytochrome P450 monooxygenenases 
653 |a CYP128A1 
653 |a Mycobacterium tuberculosis H37Rv 
653 |a molecular dynamic simulations 
653 |a azole drugs 
653 |a menaquinone 
776 |z 3-0365-0256-4 
776 |z 3-0365-0257-2 
700 1 |a Werck, Danièle  |4 edt 
700 1 |a Dansette, Patrick M.  |4 oth 
700 1 |a Werck, Danièle  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:33:33 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338073310004498&Force_direct=true  |Z 5338073310004498  |b Available  |8 5338073310004498